Laboratory Research Assistant

It’s More Than a Career, It’s a Mission.

Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day.

Our Mission

People who live with cancer – those who work to prevent it, fight it, and survive it – are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting-edge research, SCRI is redefining cancer care around the world.

The schedule for this position is Monday - Friday from 7:30AM - 4:00PM MT.

As a Lab Technician you will perform medical laboratory related procedures for patients enrolled in clinical trials. 

• You will obtain blood and other samples, vital signs, and EKGs from patients 

• You will process and ship pharmacokinetic/pharmacodynamic and all other samples according to instructions provided by study sponsor 

• You will prepare study supplies/source documents necessary for obtaining lab samples prior to patient treatment 

• You will utilize electronic medical record (EMR) for source documentation 

• You will maintain accurate freezer sample logs 

• You will ensure proper maintenance/handling of EKG machines (clinic and sponsor EKG machines) 

• You will interface with Presbyterian St. Luke’s Medical Center (P/SL) interventional radiology department for study required biopsies. You will retrieve and prepare tumor biopsy samples as requested by study sponsor. 

• You will maintain accurate records of sample acquisition and shipping. All PK samples must have source documents available in patient charts that are accurate and complete. All shipping and processing records should be maintained in the patient’s study folder You will ensure lab kits and other supplies for all active studies are adequate, all supplies are in date and lab kit inventory is maintained and kept current. Ensure all supplies are clearly labeled for study 

• You will schedule appropriate courier for sample shipments. If too late for courier, be available to make arrangements to drop samples at FedEx, UPS, etc. if necessary 

• You will ensure there is an adequate supply of dry ice available for shipments 

• You will respond to queries generated from study sponsor or contract lab regarding patient/sample data 

• You will maintain laboratory equipment and work space in all areas 

• Interface with P/SL laboratory colleagues regarding labs for research patients 

• You will register patients and order labs in the P/SL Laboratory Information System 

• You will attain and maintain competency to perform moderately complex testing in the Drug Development Unit (DDU) lab 

• You will interface with Research nurses to ensure that all research patients have correct lab kits prior to patients’ visits 

You should have for this position: 

• A High School Diploma, preferably a technical or vocational training in laboratory or phlebotomy 

• A current BLS Certification 

• Knowledge of OSHA requirements for safe handling of blood and body fluids 

• Skill in venipuncture and blood processing preferred

• Ability to multi-task in fast paced environment 

• At least one year of clinical laboratory and phlebotomy experience required 

Hourly pay range $20/hr - $27/hr. This position will be posted until April 30 2026

About Sarah Cannon Research Institute

Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 750 first-in-human clinical trials since its inception and contributed to pivotal research that has led